Well, this latest PR was very specific in the clos
Post# of 36537
(Total Views: 197)
Posted On: 10/07/2020 10:12:59 AM
Well, this latest PR was very specific in the closing of the deal. They are 100% funding the US clinical trials.
And one key point is they gave a breakdown of populations of countries impacted in the South East.
They also said the potential 1 billion instead of 150 million now
This should get everyone excited. I am hopeful we hear some positive news on the peptide testing. If that comes out and with the Swine flu showing up again with China and that could potentially impact South East Asia as well, they could work on a vaccine for that area with BK , etc..
The possibilities that Generex / NGIO are bringing forward could make a huge impact to the world.
And one key point is they gave a breakdown of populations of countries impacted in the South East.
They also said the potential 1 billion instead of 150 million now
This should get everyone excited. I am hopeful we hear some positive news on the peptide testing. If that comes out and with the Swine flu showing up again with China and that could potentially impact South East Asia as well, they could work on a vaccine for that area with BK , etc..
The possibilities that Generex / NGIO are bringing forward could make a huge impact to the world.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼